Cell and Gene Commercialization
-
Expert Solutions From Concept To Commercialization
10/19/2023
Get the assistance your teams need to translate exceptional concepts and groundbreaking science into transformative treatments that bring hope to those facing unmet medical needs.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
Leveraging Automation To Drive Down Costs For Cell Therapy Production
10/18/2023
Achieving improvements to a cell therapy workflow through automation can greatly improve the consistency of production, bolster a product’s safety and quality, reduce rework, and improve costs.
-
Transitioning From Using RUO To cGMP Chemicals For Clinical Trials
10/17/2023
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.
-
Supporting Bench To Production Applications For Multiple Industries
10/17/2023
Grow and scale up your manufacturing with the right support, and choose from 92,000+ chemicals provided through an extensive global network of 3,500+ manufacturers.
-
Build Support In The Early Days Of Advanced Therapy Entrepreneurship
10/12/2023
While more biotech companies are entering the market, advanced therapy startups can still benefit greatly from product and service options that help address challenges in the MSC or EV / exosome space.
-
The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi
10/10/2023
Explore the biggest and most troubling challenges facing the treatment of Type 1 Diabetes (T1D) and the future of cell and organ transplantation in treating T1D as well as the latest innovations in biopreservation.
-
Webinar: Reimbursement Methods For Sustainable CGT Business Models
10/10/2023
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
-
Essential Guide To Cell And Gene Therapy Commercialization
10/10/2023
After devoting time, expertise, and financial resources to developing a transformative cell or gene therapy, it is essential to ensure patients can receive all of the benefits of your innovation.
-
Improving Access And Support For Cell And Gene Therapies
10/9/2023
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.